vs

Side-by-side financial comparison of Information Services Group Inc. (III) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

Information Services Group Inc. is the larger business by last-quarter revenue ($61.2M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). Information Services Group Inc. runs the higher net margin — 4.3% vs -4.8%, a 9.0% gap on every dollar of revenue. On growth, Information Services Group Inc. posted the faster year-over-year revenue change (5.9% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $4.3M). Over the past eight quarters, Information Services Group Inc.'s revenue compounded faster (-2.4% CAGR vs -20.2%).

EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

III vs IRWD — Head-to-Head

Bigger by revenue
III
III
1.3× larger
III
$61.2M
$47.7M
IRWD
Growing faster (revenue YoY)
III
III
+53.3% gap
III
5.9%
-47.3%
IRWD
Higher net margin
III
III
9.0% more per $
III
4.3%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$70.3M more FCF
IRWD
$74.6M
$4.3M
III
Faster 2-yr revenue CAGR
III
III
Annualised
III
-2.4%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
III
III
IRWD
IRWD
Revenue
$61.2M
$47.7M
Net Profit
$2.6M
$-2.3M
Gross Margin
44.8%
Operating Margin
8.4%
14.3%
Net Margin
4.3%
-4.8%
Revenue YoY
5.9%
-47.3%
Net Profit YoY
-14.1%
-200.9%
EPS (diluted)
$0.06
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
III
III
IRWD
IRWD
Q4 25
$61.2M
$47.7M
Q3 25
$62.4M
$122.1M
Q2 25
$61.6M
$85.2M
Q1 25
$59.6M
$41.1M
Q4 24
$57.8M
$90.5M
Q3 24
$61.3M
$91.6M
Q2 24
$64.3M
$94.4M
Q1 24
$64.3M
$74.9M
Net Profit
III
III
IRWD
IRWD
Q4 25
$2.6M
$-2.3M
Q3 25
$3.1M
$40.1M
Q2 25
$2.2M
$23.6M
Q1 25
$1.5M
$-37.4M
Q4 24
$3.0M
$2.3M
Q3 24
$1.1M
$3.6M
Q2 24
$2.0M
$-860.0K
Q1 24
$-3.4M
$-4.2M
Gross Margin
III
III
IRWD
IRWD
Q4 25
44.8%
Q3 25
42.2%
Q2 25
42.2%
Q1 25
43.1%
Q4 24
41.5%
Q3 24
40.4%
Q2 24
39.5%
Q1 24
36.1%
Operating Margin
III
III
IRWD
IRWD
Q4 25
8.4%
14.3%
Q3 25
7.4%
61.8%
Q2 25
7.6%
53.2%
Q1 25
5.7%
-70.7%
Q4 24
0.3%
34.8%
Q3 24
7.0%
28.0%
Q2 24
5.7%
26.5%
Q1 24
-3.7%
14.7%
Net Margin
III
III
IRWD
IRWD
Q4 25
4.3%
-4.8%
Q3 25
4.9%
32.8%
Q2 25
3.5%
27.7%
Q1 25
2.5%
-90.9%
Q4 24
5.3%
2.5%
Q3 24
1.9%
4.0%
Q2 24
3.2%
-0.9%
Q1 24
-5.3%
-5.6%
EPS (diluted)
III
III
IRWD
IRWD
Q4 25
$0.06
$0.01
Q3 25
$0.06
$0.23
Q2 25
$0.04
$0.14
Q1 25
$0.03
$-0.23
Q4 24
$0.07
$0.03
Q3 24
$0.02
$0.02
Q2 24
$0.04
$-0.01
Q1 24
$-0.07
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
III
III
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$28.7M
$215.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$94.7M
$-261.8M
Total Assets
$211.0M
$396.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
III
III
IRWD
IRWD
Q4 25
$28.7M
$215.5M
Q3 25
$28.7M
$140.4M
Q2 25
$25.2M
$92.9M
Q1 25
$20.1M
$108.5M
Q4 24
$23.1M
$88.6M
Q3 24
$9.7M
$88.2M
Q2 24
$11.8M
$105.5M
Q1 24
$14.0M
$121.5M
Total Debt
III
III
IRWD
IRWD
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
III
III
IRWD
IRWD
Q4 25
$94.7M
$-261.8M
Q3 25
$94.7M
$-264.2M
Q2 25
$94.1M
$-308.2M
Q1 25
$95.0M
$-334.1M
Q4 24
$96.3M
$-301.3M
Q3 24
$96.6M
$-311.3M
Q2 24
$95.5M
$-321.7M
Q1 24
$95.6M
$-330.5M
Total Assets
III
III
IRWD
IRWD
Q4 25
$211.0M
$396.9M
Q3 25
$213.3M
$396.1M
Q2 25
$200.7M
$342.9M
Q1 25
$202.4M
$327.2M
Q4 24
$204.5M
$350.9M
Q3 24
$227.1M
$389.5M
Q2 24
$235.3M
$395.6M
Q1 24
$234.2M
$438.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
III
III
IRWD
IRWD
Operating Cash FlowLast quarter
$5.1M
$74.6M
Free Cash FlowOCF − Capex
$4.3M
$74.6M
FCF MarginFCF / Revenue
7.0%
156.3%
Capex IntensityCapex / Revenue
1.2%
0.0%
Cash ConversionOCF / Net Profit
1.94×
TTM Free Cash FlowTrailing 4 quarters
$25.0M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
III
III
IRWD
IRWD
Q4 25
$5.1M
$74.6M
Q3 25
$11.1M
$47.6M
Q2 25
$11.9M
$-15.1M
Q1 25
$978.0K
$20.0M
Q4 24
$6.6M
$15.2M
Q3 24
$8.8M
$9.9M
Q2 24
$2.2M
$33.5M
Q1 24
$2.3M
$45.0M
Free Cash Flow
III
III
IRWD
IRWD
Q4 25
$4.3M
$74.6M
Q3 25
$9.5M
$47.6M
Q2 25
$11.1M
$-15.1M
Q1 25
$141.0K
$19.9M
Q4 24
$6.0M
Q3 24
$8.4M
$9.9M
Q2 24
$1.3M
$33.4M
Q1 24
$1.3M
$44.9M
FCF Margin
III
III
IRWD
IRWD
Q4 25
7.0%
156.3%
Q3 25
15.2%
39.0%
Q2 25
18.0%
-17.7%
Q1 25
0.2%
48.4%
Q4 24
10.4%
Q3 24
13.7%
10.8%
Q2 24
2.0%
35.4%
Q1 24
2.0%
60.0%
Capex Intensity
III
III
IRWD
IRWD
Q4 25
1.2%
0.0%
Q3 25
2.5%
0.0%
Q2 25
1.4%
0.0%
Q1 25
1.4%
0.1%
Q4 24
0.9%
0.0%
Q3 24
0.6%
0.0%
Q2 24
1.4%
0.1%
Q1 24
1.6%
0.1%
Cash Conversion
III
III
IRWD
IRWD
Q4 25
1.94×
Q3 25
3.62×
1.19×
Q2 25
5.46×
-0.64×
Q1 25
0.66×
Q4 24
2.15×
6.74×
Q3 24
7.66×
2.71×
Q2 24
1.07×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons